drugset / Trial / NCT01344083

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis

NCT01344083

Phase 2 Completed 60 enrolled Laboratoires Thea
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to compare the efficacy and the safety of T1210 versus Olopatadine eye drops in the topical treatment of seasonal allergic conjunctivitis.

Timeline

Start
2011-04
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olopatadine Other / unclassified 2 unknown Topical
Subject T1210 Unknown 2 unknown Topical

Indications